These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38117963)
1. Comparison of Class-Specific Side Effects Across Preventative Pharmacologic Therapies for Kidney Stone Disease. Hsi RS; Crivelli JJ; Yan PL; Shahinian V; Hollingsworth JM Urol Pract; 2024 Jan; 11(1):172-178. PubMed ID: 38117963 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease. Hsi RS; Yan PL; Crivelli JJ; Goldfarb DS; Shahinian V; Hollingsworth JM Urology; 2022 Aug; 166():111-117. PubMed ID: 35545149 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Selective Versus Empiric Pharmacologic Preventative Therapy With Kidney Stone Recurrence. Hsi RS; Yan PL; Goldfarb DS; Egbuji A; Si Y; Shahinian V; Hollingsworth JM Urology; 2021 Mar; 149():81-88. PubMed ID: 33352163 [TBL] [Abstract][Full Text] [Related]
4. Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans. Song S; Thomas IC; Ganesan C; Sohlberg EM; Chertow GM; Liao JC; Conti S; Elliott CS; Pao AC; Leppert JT Clin J Am Soc Nephrol; 2019 Dec; 14(12):1773-1780. PubMed ID: 31712387 [TBL] [Abstract][Full Text] [Related]
5. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate. Odvina CV; Mason RP; Pak CY Am J Ther; 2006; 13(2):101-8. PubMed ID: 16645424 [TBL] [Abstract][Full Text] [Related]
6. Medication Nonadherence and Effectiveness of Preventive Pharmacological Therapy for Kidney Stones. Dauw CA; Yi Y; Bierlein MJ; Yan P; Alruwaily AF; Ghani KR; Wolf JS; Hollenbeck BK; Hollingsworth JM J Urol; 2016 Mar; 195(3):648-52. PubMed ID: 26485048 [TBL] [Abstract][Full Text] [Related]
7. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Fink HA; Wilt TJ; Eidman KE; Garimella PS; MacDonald R; Rutks IR; Brasure M; Kane RL; Ouellette J; Monga M Ann Intern Med; 2013 Apr; 158(7):535-43. PubMed ID: 23546565 [TBL] [Abstract][Full Text] [Related]
8. The Effect of Thiazide and Potassium Citrate Use on the Health Related Quality of Life of Patients with Urolithiasis. Raffin EP; Penniston KL; Antonelli JA; Viprakasit DP; Averch TD; Bird VG; Chew BH; Sivalingam S; Sur RL; Nakada SY; Pais VM J Urol; 2018 Dec; 200(6):1290-1294. PubMed ID: 29913138 [TBL] [Abstract][Full Text] [Related]
9. Preventive treatment of nephrolithiasis with alkali citrate--a critical review. Mattle D; Hess B Urol Res; 2005 May; 33(2):73-9. PubMed ID: 15875173 [TBL] [Abstract][Full Text] [Related]
10. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Ruml LA; Gonzalez G; Taylor R; Wuermser LA; Pak CY Am J Ther; 1999 Jan; 6(1):45-50. PubMed ID: 10423646 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. Pearle MS; Roehrborn CG; Pak CY J Endourol; 1999 Nov; 13(9):679-85. PubMed ID: 10608521 [TBL] [Abstract][Full Text] [Related]
13. Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options. Sfoungaristos S; Gofrit ON; Yutkin V; Pode D; Duvdevani M Expert Opin Pharmacother; 2015 Jun; 16(8):1209-18. PubMed ID: 25881654 [TBL] [Abstract][Full Text] [Related]
14. Effects of thiazides and new findings on kidney stones and dysglycemic side effects. Bargagli M; Anderegg MA; Fuster DG Acta Physiol (Oxf); 2024 Jul; 240(7):e14155. PubMed ID: 38698738 [TBL] [Abstract][Full Text] [Related]
15. Associations Between Provider Specialty and Use of Follow-up Testing Among Patients on Preventive Pharmacological Therapy for Urinary Stone Disease. Crivelli JJ; Yan PL; Shahinian V; Hsi RS; Hollingsworth JM Urol Pract; 2023 Jul; 10(4):400-406. PubMed ID: 37341368 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Selective vs Empiric Pharmacologic Preventive Therapy of Kidney Stone Recurrence With High-Risk Features. Hsi RS; Yan PL; Crivelli JJ; Goldfarb DS; Shahinian V; Hollingsworth JM Urology; 2022 Jun; 164():74-79. PubMed ID: 35182586 [TBL] [Abstract][Full Text] [Related]
17. Urinary metabolic profile and stone composition in kidney stone formers with and without heart disease. Bargagli M; Moochhala S; Robertson WG; Gambaro G; Lombardi G; Unwin RJ; Ferraro PM J Nephrol; 2022 Apr; 35(3):851-857. PubMed ID: 34152561 [TBL] [Abstract][Full Text] [Related]
18. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi]. Hess B Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986 [TBL] [Abstract][Full Text] [Related]
19. Thiazides for kidney stone recurrence prevention. Bargagli M; Trelle S; Bonny O; Fuster DG Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):427-432. PubMed ID: 38606682 [TBL] [Abstract][Full Text] [Related]
20. Association of Thiazide Diuretics With Diabetes Progression, Kidney Disease Progression, Cardiovascular Outcomes, and Death Among Patients With Diabetes Who Initiate Statins. Afify H; Gonzalez-Morales U; Asmar A; Alvarez CA; Mansi IA Am J Cardiol; 2023 Sep; 203():274-284. PubMed ID: 37516035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]